Joy Ho

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

Medicine, Hematology, Pharmacotherapy +15

Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8+CD57+CD28− compartment

Daniel Sze, Gillian Giesajtis, Ross Brown et al. · Blood · 2001 · 133 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Post-treatment Mortality Among Patients With Tuberculosis: A Prospective Cohort Study of 10 964 Patients in Vietnam

Greg J. Fox, V.N. Nguyen, Nho-Thai Dinh et al. · Clinical Infectious Diseases · 2018 · 42 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +13

Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry

Krystal Bergin, Elizabeth Moore, Zoe McQuilten et al. · BMC Medical Research Methodology · 2016 · 36 citations · Full text

Medicine, Hematology, Clinical Epidemiology +11

Long-Term Follow-up of Tisagenlecleucel in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Updated Analysis of Juliet Study

Stephen J. Schuster, Michael Bishop, Constantine S. Tam et al. · Biology of Blood and Marrow Transplantation · 2019 · 35 citations · Full text

Medicine, Hematology, Oncology +17